{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:12:47Z","timestamp":1793167967446,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":3225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.7861\/clinmedicine.15-3-252","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T04:55:49Z","timestamp":1433134549000},"page":"252-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Oluwafikunayo","family":"Orekoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Paine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.15-3-252_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0016-5085(67)80140-9","article-title":"The syndrome of ileal disease and the broken enterohepatic circulation: cholerhetic enteropathy","volume":"52","author":"Hofmann","year":"1967","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.15-3-252_bib2","first-page":"448","article-title":"Bile acid malabsorption in persistent diarrhoea","volume":"34","author":"Smith","year":"2000","journal-title":"J R Coll Physicians Lond"},{"key":"10.7861\/clinmedicine.15-3-252_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7861\/clinmedicine.10-2-124","article-title":"Bile acid malabsoption: a forgotten diagnosis?","volume":"10","author":"Khalid","year":"2010","journal-title":"Clin Med"},{"key":"10.7861\/clinmedicine.15-3-252_bib4","series-title":"Diagnostics consultation document: SeHCAT (tauroselcholic [75selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption","year":"2012"},{"key":"10.7861\/clinmedicine.15-3-252_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0300-5089(21)00739-2","article-title":"Bile acid-induced diarrhoea","volume":"15","author":"Fromm","year":"1986","journal-title":"Clin Gastroenterol"},{"key":"10.7861\/clinmedicine.15-3-252_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.35.1.90","article-title":"Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT","volume":"35","author":"Nyhlin","year":"1994","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.15-3-252_bib7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/gut.32.9.1004","article-title":"Idiopathic bile acid malabsorption \u2013 a review of clinical presentation, diagnosis, and response to treatment","volume":"32","author":"Williams","year":"1991","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.15-3-252_bib8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/00365520310004461","article-title":"Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test","volume":"38","author":"Wildt","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.7861\/clinmedicine.15-3-252_bib9","first-page":"351","article-title":"Bile acid malabsorption in patients with post-vagotomy diarrhoea","volume":"81","author":"al-Hadrani","year":"1992","journal-title":"Ann Chir Gynaecol"},{"key":"10.7861\/clinmedicine.15-3-252_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/pgmj.68.798.272","article-title":"Use of the SeHCAT test in the investigation of diarrhoea","volume":"68","author":"Ford","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.7861\/clinmedicine.15-3-252_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/apt.12804","article-title":"Letter: bile acid malabsorption what is the prevalence in patients with chronic diarrhoea","volume":"40","author":"Kurien","year":"2014","journal-title":"?Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.15-3-252_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","article-title":"Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome","volume":"30","author":"Wedlake","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.15-3-252_bib13","first-page":"126","article-title":"Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)","volume":"23","author":"Merrick","year":"1982","journal-title":"J Nucl Med"},{"key":"10.7861\/clinmedicine.15-3-252_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0016-5085(83)80167-X","article-title":"Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment","volume":"84","author":"Nyhlin","year":"1983","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.15-3-252_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.290.6469.665","article-title":"Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention","volume":"290","author":"Merrick","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.7861\/clinmedicine.15-3-252_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2982.2012.01953.x","article-title":"Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea","volume":"24","author":"Gracie","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.7861\/clinmedicine.15-3-252_bib17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cgh.2013.04.029","article-title":"Methods for diagnosis of bile acid malabsorption in clinical practice","volume":"11","author":"Vijayvargiya","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.15-3-252_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","article-title":"A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis","volume":"7","author":"Walters","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.15-3-252_bib19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cgh.2009.07.026","article-title":"Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release","volume":"7","author":"Hofmann","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.15-3-252_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042737-199602000-00005","article-title":"Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea","volume":"8","author":"Brydon","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.15-3-252_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/bmb\/ldp032","article-title":"Recent advances in the understanding of bile acid malabsorption","volume":"92","author":"Pattni","year":"2009","journal-title":"Br Med Bull"},{"key":"10.7861\/clinmedicine.15-3-252_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrgastro.2014.32","article-title":"Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy","volume":"11","author":"Walters","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.15-3-252_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/apt.12466","article-title":"Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention","volume":"38","author":"Pattni","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.15-3-252_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ctg.2012.10","article-title":"Fibroblast growth factor 19 and 7\u03b1-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea","volume":"3","author":"Pattni","year":"2012","journal-title":"Clin Transl Gastroenterol"},{"key":"10.7861\/clinmedicine.15-3-252_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/apt.12684","article-title":"Systematic review: the management of chronic diarrhoea due to bile acid malabsorption","volume":"39","author":"Wilcox","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.15-3-252_bib26","first-page":"437","article-title":"Discontinuation rates of cholesterol-lowering medications: implications for primary care","volume":"5","author":"Hiatt","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.7861\/clinmedicine.15-3-252_bib27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.crohns.2014.05.009","article-title":"Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study","volume":"8","author":"Beigel","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.7861\/clinmedicine.15-3-252_bib28","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.clinthera.2009.11.027","article-title":"Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire","volume":"31","author":"Wedlake","year":"2009","journal-title":"Clin Ther"},{"key":"10.7861\/clinmedicine.15-3-252_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ajhp\/59.10.932","article-title":"Colesevelam hydrochloride","volume":"59","author":"Steinmetz","year":"2002","journal-title":"Am J Health Syst Pharm"},{"key":"10.7861\/clinmedicine.15-3-252_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/gut.2004.054486","article-title":"New treatment for bile salt malabsorption","volume":"54","author":"Puleston","year":"2005","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.15-3-252_bib31","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1023\/A:1011927302076","article-title":"Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea","volume":"46","author":"Fernandez-Ba\u00f1ares","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.7861\/clinmedicine.15-3-252_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01395507","article-title":"Dose-related effects of chenodeoxycholic acid in the rabbit colon","volume":"25","author":"Camilleri","year":"1980","journal-title":"Dig Dis Sci"},{"key":"10.7861\/clinmedicine.15-3-252_bib33","first-page":"661","article-title":"Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon","volume":"94","author":"Chadwick","year":"1979","journal-title":"J Lab Clin Med"},{"key":"10.7861\/clinmedicine.15-3-252_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejim.2011.08.013","article-title":"Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea","volume":"22","author":"Borghede","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.7861\/clinmedicine.15-3-252_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2036.1998.00388.x","article-title":"Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine","volume":"12","author":"Sinha","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.15-3-252_bib36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.10263","article-title":"Colesevelam hydrochloride: a novel bile acid-binding resin","volume":"35","author":"Aldridge","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.7861\/clinmedicine.15-3-252_bib37","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3109\/00365521.2011.574728","article-title":"Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms","volume":"46","author":"Kurien","year":"2011","journal-title":"Scand J Gastroenterol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824015525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824015525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.15-3-252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:33:55Z","timestamp":1761460435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824015525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1470211824015525"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.15-3-252","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.15-3-252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2015. All rights reserved.","name":"copyright","label":"Copyright"}]}}